Active, Not Recruiting
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma
NCT05022901
- Conditions
- Eye Diseases, Eye Neoplasms, Melanoma, +13 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Duke University Medical Center Durham, North Carolina, United States
- The Ohio State University Columbus, Ohio, United States